Sell The Gap Sprint · Healthcare AI & MedTech

The deals you should win — but don't.

You have a better product. The buyer knows it. They've seen the demo, they like your team, they agree you're ahead of what they're running today. And then nothing moves. The deal stalls, the incumbent's renewal quietly goes through, and you're told "maybe next cycle."

An operator on a hillside looking out over a city at dusk
Three weeks · Fixed fee · Run against your live pipeline
Why it happens

Displacement is a different sale, and almost nobody runs it differently.

The buyer who agrees you're superior still has to rip out a system people are trained on, spend political capital to justify the switch, and personally own the risk if it goes wrong. Faced with that, "good enough and already installed" wins more often than it should. Most teams answer with the new-logo playbook — features, demos, ROI decks — against a problem that is actually about switching costs, internal politics, and risk ownership. The result is a pipeline full of accounts that love you and won't move.

Where they are

Running the incumbent

Installed, trained on, budgeted — and nobody's job is on the line for keeping it.

Barrier 01

Switching cost

Migration, retraining, and workflow disruption the buyer absorbs personally.

Barrier 02

Political capital

Someone inside has to argue against a decision the organization already made.

Barrier 03

Risk ownership

If the switch goes badly, one named person wears it. That closes more deals than price.

Where you need them

Switched to you

The change is defensible up the chain — and the champion can carry it there alone.

No two accounts sit at the same point on that line. The sprint places each of your live opportunities on it, then builds the specific route from where it is to signed.

What we do together

A displacement strategy, built and run across your live opportunities.

Not a workshop and not a framework lecture. Over three weeks we work your named accounts, in the order they can actually be won.

01

Map the displacement arc

For each target account, we map exactly where it sits — what's entrenched, why it's sticky, and the specific path from "using the incumbent" to "switched to you." No two accounts are at the same place; each gets its own route.

02

Arm your internal champions

Someone inside the account has to spend political capital to switch. We equip that person with the narrative, the objection-handling, and the internal business case they need to sell the change to their boss — because you don't win the account, your champion does.

03

Build the evidence and economic case

We construct the proof and the ROI story that make switching defensible — the case a buyer can take up the chain without personal risk. This is what converts "I like it" into "I can justify this."

04

Prioritize the winnable

We rank your named pipeline by displaceability, so your team spends its energy on the accounts that will actually move — not the ones that will admire you for another year.

What you walk away with

Not a strategy deck that sits in a drawer.

The actual tools your team runs the week after we finish.

Why me

This isn't displacement theory from someone who read about sales.

I displaced an entrenched incumbent at a top-tier academic medical center — walking in against a vendor already embedded in the workflow, and winning the account. It's the method from someone who has won the exact fight you're in.

Nathan Klarer
Founder & Principal

A commercial operator and company builder with a technical foundation — bioengineering and AI by training, commercial leadership by trade. Nathan has built and deployed clinical AI in live hospital settings, published the research behind it, and sold into health systems against installed competition.

  • Displacement
    Won an account held by an embedded vendorTop-tier academic medical center, incumbent already in the clinical workflow.
  • Clinical AI
    Lead company published in Nature & NEJMSepsis-prediction and hospital-quality AI, deployed at major US academic health systems.
  • Exits
    Two realized exitsFounding-team participation in a NASDAQ IPO (Core Scientific); acquisition of Bridgecrest Medical.
  • Operating
    Scaled to 45+ employeesBuilt a data and AI services company from zero over roughly eight years.
Surf breaking against a sunlit coastline at sunset
The details

Fixed scope, fixed fee, three weeks.

Scoped before we start, so there is nothing to true up at the end. The work runs against your real pipeline from day one.

Bonus. The full fee is credited toward a retainer if you engage me for ongoing commercial leadership within 30 days.

3 weeks
Focused and hands-on
$17,500
Fixed investment
Let's talk

If you're sitting on accounts that should be yours, let's map how to win them.

Tell me which accounts are stalled and who's installed. I'll respond directly.

Book a call →
BasedAustin, Texas · Working internationally